Order byBest matchMost fresh

Cell, gene therapy makers lose a champion at FDA

Digest more
Top News
Impacts
His exit leaves cell and gene therapy developers without their biggest proponent at the FDA.
From Yahoo
RBC Capital analyst Brian Abrahams warned that Marks’ exit could lead to disruptions at the FDA, affecting drug approvals and regulatory flexibility.
From Business Insider

Read more on News Digest

Cell, gene therapy makers lose a champion at FDA with exit of Peter Marks
Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.
As FDA's Peter Marks resigns, industry watchers size up vaccine, cell and gene therapy hits
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency is heading for the exit. | In resigning as director of the FDA’s Center for Biologics Evaluation and Research,
Top FDA vaccine official Peter Marks resigns in opposition to RFK Jr.
The Food and Drug Administration’s top vaccine regulator Peter Marks has resigned, citing Sec. Kennedy Robert F. Kennedy Jr.’s “misinformation and lies” around immunization.
Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research
Drugmakers sink after key FDA official ousted as Trump plans health overhaul
Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official, Peter Marks, had been forced to resign, the most high-profile exit at the regulator as the Trump administration undertakes an overhaul of federal health agencies.
Biotech Investors Rush for the Exits After FDA Official Resigns
Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and champio
Who Is Dr. Peter Marks? FDA’s Top Vaccine Official Quits, Citing RFK Jr.’s ‘Misinformation And Lies.’
Marks offered his resignation while citing Kennedy’s “misinformation and lies” and an “unprecedented assault on scientific truth” impacting public health.
Dr. Peter Marks, top vaccine official at FDA, resigns and criticizes RFK Jr.
Dr. Peter Marks, the top vaccine official at the Food and Drug Administration, wrote in a letter that he was resigning from his position.
Peter Marks, top FDA vaccine official, forced to resign
Dr. Peter Marks, the top vaccine regulator at the U.S. Food and Drug Administration, was forced to resign, citing Health and Human Services Secretary Robert F. Kennedy Jr.'s "misinformation and lies" around immunization.
FDA’s top vaccine scientist, Dr. Peter Marks, is out
Dr. Peter Marks, the Food and Drug Administration’s top vaccine regulator, has resigned, an official at the Department of Health and Human Services said Friday.
Top vaccine official Peter Marks forced out at FDA, WSJ reports
The U.S. Food and Drug Administration's top vaccine official, Peter Marks, has been pushed out, the Wall Street Journal reported on Friday. Marks, who played a key role in U.S. President Donald Trump's first term in developing COVID-19 vaccines,
Explore more
STAT2d
Peter Marks, FDA’s top vaccine regulator, forced out
Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
STAT2d
FDA’s ‘key man’ Peter Marks is out. Biotech investors will now deal with the consequences
Peter Marks’ ouster comes at a time when the sector is already suffering through a years-long public markets slump.
BioSpace4h
FDA Job Cuts, Key Departures Bring ‘Revolving Door’ Debate Front and Center
With the recently announced layoffs of 3,500 FDA staffers and exits of branch directors Patrizia Cavazzoni and Peter Marks, there could be a wealth of talent available to biopharma companies. Does this pose an ethical quandary?
FDA misses deadline for decision on Novavax's COVID-19 vaccine, source says
It comes on the heels of the FDA's top vaccine scientist Peter Marks' exit from the agency, which will be effective April 5. Marks, who played a key role in developing COVID-19 vaccines during U.S. President Donald Trump's first term,
Feedback